Lijun Li
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Multimodal clinical, sleep, and autonomic correlates across the depressive spectrum: a cross-sectional study.
Journal: Frontiers in psychology
Published: March 18, 2026
Drug Interactions of Vebreltinib, a Novel Type I c-Met Inhibitor, Coadministration With Rifampin or Itraconazole in Healthy Participants.
Journal: Clinical and translational science
Published: December 07, 2025
Unravelling the human disposition of [14C]-vebreltinib: Faecal recovery of parent drug and a major circulating metabolite defines its mass balance profile.
Journal: British journal of clinical pharmacology
Published: December 01, 2025
Computational and neural correlates of Gain-loss differences in intertemporal choice.
Journal: Consciousness and cognition
Published: October 08, 2025
GYG1 as a Dual Biomarker of Glucagon-Like Peptide-1 Receptor Agonist Weight-Loss Response: Findings from an Integrative Multi-Omics Substudy of a Phase II Trial.
Journal: Endocrinology and metabolism (Seoul, Korea)
Published: September 03, 2025
GYG1 as a Dual Biomarker of Glucagon-Like Peptide-1 Receptor Agonist Weight-Loss Response: Findings from an Integrative Multi-Omics Substudy of a Phase II Trial.
Journal: Endocrinology and metabolism (Seoul, Korea)
Published: September 03, 2025
Effect of 24-h and 36-h acute total sleep deprivation on human attention: An activation likelihood estimation meta-analysis.
Journal: International journal of psychophysiology : official journal of the International Organization of Psychophysiology
Published: June 26, 2025
Bifidobacterium animalis subsp. Lactis A6 alleviates comorbid constipation and depression by rebalancing tryptophan metabolism.
Journal: Science bulletin
Published: January 02, 2025
Uric Acid, Arterial Stiffness and Blood Pressure: A Population-Based Cohort Study.
Journal: Health science reports
Published: November 29, 2024
Evaluation of drug-drug interactions of a novel potent FLT3 inhibitor SKLB1028 in healthy subjects.
Journal: Clinical and translational science
Published: April 10, 2024
Safety and immunogenicity of the COVID-19 mRNA vaccine CS-2034: A randomized, double-blind, dose-exploration, placebo-controlled multicenter Phase I clinical trial in healthy Chinese adults.
Journal: The Journal of infection
Published: August 01, 2023
An open-label study to explore the optimal design of CYP3A drug-drug interaction clinical trials in healthy Chinese people.
Journal: Pharmacology research & perspectives
Published: July 20, 2023
Last Updated: 09/26/2026